Cargando…

Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines

Testicular germ cell tumors (TGCTs) represent a well curable malignity due to their exceptional response to cisplatin (CDDP). Despite remarkable treatment results, approximately 5% of TGCT patients develop CDDP resistance and die. Exceptional curability makes TGCTs a highly valuable model system for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roška, Jan, Wachsmannová, Lenka, Hurbanová, Lenka, Šestáková, Zuzana, Mueller, Thomas, Jurkovičová, Dana, Chovanec, Miroslav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771712/ https://www.ncbi.nlm.nih.gov/pubmed/33473258 http://dx.doi.org/10.18632/oncotarget.27844

Ejemplares similares

Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours
por: Roška, Jan, et al.
Publicado: (2023)

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours
por: Cierna, Zuzana, et al.
Publicado: (2020)

The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer
por: Sestakova, Zuzana, et al.
Publicado: (2016)

Response of the Urothelial Carcinoma Cell Lines to Cisplatin
por: Holíčková, Andrea, et al.
Publicado: (2022)

Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
por: Kalavska, Katarina, et al.
Publicado: (2021)

Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
por: Singh, Ratnakar, et al.
Publicado: (2019)

Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity
por: Schaffrath, Judith, et al.
Publicado: (2017)

Immunotherapy in Testicular Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2020)

Comprehensive Assessment of Selected Immune Cell Subpopulations Changes in Chemotherapy-Naïve Germ Cell Tumor Patients
por: Kalavska, Katarina, et al.
Publicado: (2022)

Detection of Specific Immune Cell Subpopulation Changes Associated with Systemic Immune Inflammation–Index Level in Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2022)

Intricacies of Radiographic Assessment in Testicular Germ Cell Tumors
por: Makovník, Marek, et al.
Publicado: (2021)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

Down-regulation of traditional oncomiRs in plasma of breast cancer patients
por: Jurkovicova, Dana, et al.
Publicado: (2017)

Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
por: Bakardjieva-Mihaylova, Violeta, et al.
Publicado: (2019)

Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
por: Sark, M. W., et al.
Publicado: (1995)

Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
por: Schweyer, S, et al.
Publicado: (2004)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells
por: Fung, M K L, et al.
Publicado: (2006)

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
por: Burger, H., et al.
Publicado: (1998)

Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors
por: Kalavska, Katarina, et al.
Publicado: (2017)

Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential
por: Wagner, Alexandra, et al.
Publicado: (2022)

Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors
por: Chovanec, Michal, et al.
Publicado: (2023)

Effect of the PARP inhibitor veliparib on germ cell tumor cell lines
por: Schmidtova, Silvia, et al.
Publicado: (2022)

Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours
por: Harpelunde Poulsen, K., et al.
Publicado: (2020)

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Prognostic value of serum carbonic anhydrase IX in testicular germ cell tumor patients
por: Kalavska, Katarina, et al.
Publicado: (2016)

Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice
por: Chovanec, Michal, et al.
Publicado: (2018)

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
por: Fichtner, A., et al.
Publicado: (2022)

Overcoming Chemotherapy Resistance in Germ Cell Tumors
por: Országhová, Zuzana, et al.
Publicado: (2022)

Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide.
por: Pera, M. F., et al.
Publicado: (1995)

Acute Exposure to Bisphenol A Causes Oxidative Stress Induction with Mitochondrial Origin in Saccharomyces cerevisiae Cells
por: Ďurovcová, Ivana, et al.
Publicado: (2021)

Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
por: Lobo, João, et al.
Publicado: (2020)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
por: Kalinkova, Lenka, et al.
Publicado: (2020)

Glycan signatures for the identification of cisplatin‐resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG)
por: Hires, Michal, et al.
Publicado: (2022)

βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
por: Chovanec, Michal, et al.
Publicado: (2018)

Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021)

Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
por: Nitzsche, B, et al.
Publicado: (2012)

Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors
por: Tuzel, Emre, et al.
Publicado: (2015)

Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways
por: Caggiano, Cinzia, et al.
Publicado: (2021)

Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors
por: Chovanec, Michal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bp24p5pkuth67kqnv8218qkg1s